US: 800.298.5699
Int'l: +1.240.747.3093
Matching geography
Reports matching your search in:
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!

Biomarkers Market Research Reports & Industry Analysis

The high specificity required of biomarkers in research, drug development and clinical diagnostics creates significant diversity in the global biomarkers market. The greatest focus in biomarkers development is oncology with cancer biomarkers occupying the largest space at over 25% of the market. Biomarkers are parameters or analytes integral to or associated with a biochemical, anatomical, pathogenic, pharmacologic or molecular (genetic) process of clinical interest.

Biomarker discovery continues to power the development of in vitro diagnostic (IVD) tests used to diagnose disease and health conditions, predict patient response to therapy, and monitor therapeutic effects and patient health. Ideal biomarkers have excellent sensitivity and specificity in terms of identifying disease, determining disease state, or evaluating patient response to therapy. Biomarkers are generally proteins (products of gene expression) or nucleic acid sequences (either RNA or DNA); small molecules that are products of metabolism may also serve as biomarkers.

The proliferation of biomarkers is a result of greater clinical understanding of the interconnections between genetics, proteomics and gene expression, disease susceptibility, disease manifestation, and disease susceptibility to select therapies. Biomarkers can be classified as natural history markers (allow for the detection and isolation of a particular cell type), drug activity markers (indicate patient response to pharmological intervention), or surrogate markers (markers that can be used as an alternative to traditional endpoints such as morbidity and mortality to evaluate the effectiveness of a therapy in treating disease). Genomic research is expected to further expand the availability of biomarkers for various diseases and make significant contributions to personalized medicine.

In addition to cancer biomarkers, biomarkers are also available for cardiac function and episodes, other cardiovascular conditions, coagulation or hemostasis, endocrine function, blood sugar management, autoimmune disorders, inflammation, specific infectious diseases, sepsis, and neurological disorders. Over half of the biomarkers market exists in clinical applications, the rest in drug development, research and clinical trial applications. Biomarkers are broadly used for disease risk assessment, diagnosis, screening, treatment or therapy selection, and therapeutic monitoring.

RSS Feeds

Biomarkers Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  
Cancer Drugs with Biomarker Development: Analytical Tool
8/22/2016 | published by: BioSeeker Group AB
... from a business development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage ...  |  read more...
USD 20,250
Cardiac Markers
6/16/2016 | published by: Kalorama Information
... of Cardiovascular Disease Selected Biomarkers and Biomarker Panels for Cardiovascular Disease, and Companies Developing/Marketing These Biomarkers Selected Lipid Biomarkers, and Companies Developing/Marketing These Biomarkers Biomarkers are biological or biochemical molecules, or genetic changes, or other ...  |  read more...
USD 1,995
Cardiac Marker Diagnostic Testing Markets
8/1/2016 | published by: TriMark Publications
... cardiac arrest (SCA), acute myocardial infarction (AMI), congestive heart failure (CHF) and atherosclerosis. Every year, an estimated 17 million people worldwide die from a CVD. This TriMark Publications report describes the specific market segment of ...  |  read more...
USD 5,500
MicroRNAs in Cancer Drug Pipeline Update
8/4/2016 | published by: BioSeeker Group AB
... minimal toxicities either as a monotherapy or perhaps even more likely in a combinatorial drug setting. miRNA may also hold great potential as biomarkers, albeit a lot of work is a head of us and ...  |  read more...
USD 6,750
Biomarkers Market Analysis By Type (Safety, Efficacy, Validation), By Application (Diagnostics, Drug Development, Personalized Medicine), By Disease (Oncology, Cardiovascular, Neurology, Immunology) And Segment Forecasts To 2024
8/2/2016 | published by: Grand View Research
... over USD 78.2 billion by 2024, according to a new report by Grand View Research, Inc. The growing demand for companion diagnostics and the rising adoption of personalized medicine are the key factors propelling the ...  |  read more...
USD 4,700
Liquid Biopsy Market by Cancer Type (Lung, Breast, Colorectal, Prostate, Liver), Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA), Product (Instruments, Software), End User (Reference Laboratory, Research Centers) - Forecast to 2021
7/21/2016 | published by: MarketsandMarkets
... for Research on Liquid Biopsy and Technological Advancements to Boost the Growth of the Liquid Biopsy Market The liquid biopsy market is expected to reach USD 1.66 billion by 2021 from USD 0.58 billion in ...  |  read more...
USD 5,650
Biomarkers: Technologies and Global Markets
6/1/2016 | published by: BCC Research
... (CAGR) of 13.8% from 2015 to 2020, increasing from $50.6 billion in 2015 to $96.6 billion in 2020. This report provides: An overview of the global markets for biomarkers. Analyses of global market trends, with ...  |  read more...
USD 6,650
Cancer Biomarkers Market outlook - Market size, segmentation, market share and competitive landscape (2016-2021)
6/1/2016 | published by: Mordor Intelligence LLP
... billion by 2019, growing at a CAGR of 14.60% during the forecast period 2011 to 2019. Biomarkers are chemical, physical or biological parameters which can be used to indicate disease states. Cancer biomarkers offers high ...  |  read more...
USD 500
Global Central Nervous System (CNS) Biomarkers Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022
6/5/2016 | published by: Occams Business Research & Consultancy
... or progress of effects of treatment. It helps in understanding various chronic diseases, its effects on exposure to certain environmental conditions and also in identification of people who are at high risk of developing the ...  |  read more...
USD 3,900
Cardiac Biomarkers: Technologies and Global Markets
6/1/2016 | published by: BCC Research
... growth rate (CAGR) of 12.4% from 2015 to 2020, increasing to over $8.8 billion in 2020. This report provides: An overview of the global market for cardiac biomarkers and related technologies. Analyses of global market ...  |  read more...
USD 6,650
Global Cardiac Biomarkers Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022
6/8/2016 | published by: Occams Business Research & Consultancy
... 19.5% from 2016 to 2022. The prevention of cardiac diseases, by active monitoring the heart conditions by using cardiac biomarker testing is the newest approach for obtaining fastest output of immediate diagnosing and treatment of ...  |  read more...
USD 3,900
MicroRNA Tools and Services Market
5/3/2016 | published by: Kalorama Information
... to clinical applications. The report includes the following market information: Estimated Market Breakdown by Tools and Services, 2015 Estimated Market Breakdown by Geographic Region, 2015 (North America, Europe, ROW) Global Revenues and Forecast for the ...  |  read more...
USD 4,200
Growth Potential of Specific Biomarker-Based Tests: White Paper
2/9/2016 | published by: Kalorama Information
... for all tests are provided, as well as a list of companies that are involved in the market.  Markers discussed include:  CEA, HIV Rapid Marker-Based, AFP, FOB, Rapid PSA, NMP22, Cardiac Markers-Acute, C difficile Marker-Based, ...  |  read more...
Biomarker-Based Tests: Faster Revenue Growth
2/26/2016 | published by: Kalorama Information
Tests with biomarker basis are demonstrating faster revenue growth than the IVD market.  This White Paper discusses the trend, and defines companies in the marketplace.  Based on Kalorama Informaton's Biomarker Market reporting.    |  read more...
The Global Market for Biomarkers (Cancer Markers, Cardiac Markers, Immunological Disease Markers, Infectious Disease Markers, Others)
12/10/2015 | published by: Kalorama Information
... markets for biomarkers. The report provides a market analysis for six broad areas of medical biomarkers: The Market for Cancer Biomarkers The Market for Cardiovascular Disease Biomarkers The Market for Immunological Disease Biomarkers The Market ...  |  read more...
USD 4,200
2016-2020 Immunodiagnostics: Spot Fast-Growing Market Segments - Therapeutic Drug Monitoring (TDM), Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse
3/18/2016 | published by:
... future trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and market shares; compares ...  |  read more...
USD 24,500
CD19 Therapeutics Market, 2016 - 2030
3/31/2016 | published by: Roots Analysis
... an immune response. Immunotherapies exploit the body's innate potential to specifically target a particular molecular antigen and mount an efficient immune response against the cells bearing the diseased signature. Currently, four major types of immunotherapies ...  |  read more...
USD 2,199
Exosome Diagnostics and Therapeutics: Global Markets
3/1/2016 | published by: BCC Research
... (CAGR) of 47.3%. This report provides: An overview of the global markets and related technologies for exosome diagnostics and therapeutics. Analyses of global market trends, with data from 2015, estimates for 2016, and projections of ...  |  read more...
USD 6,650
Cardiac Biomarkers (Clinical Laboratory Testing, Point-of-Care Testing (POCT), Acute myocardial infarction (AMI), etc.)
4/1/2016 | published by: Global Industry Analysts
... of Care Testing. The Global, US and European markets are further analyzed by the following Test Types: Cardiac Troponin, BNP and NT-proBNP, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, ...  |  read more...
USD 4,500
Global Biomarker Partnering Terms and Agreements 2010-2016: Deal trends, players and financials
3/1/2016 | published by: Current Partnering
... Trends in biomarker partnering deals Biomarker partnering agreement structure Biomarker partnering contract documents Top biomarker deals by value Most active biomarker dealmakers The Global Biomarker Partnering 2010-2016 report provides comprehensive understanding and unprecedented access to ...  |  read more...
USD 2,995
Global Commercializing Biomarkers Industry 2016 Market Research Report
3/18/2016 | published by: 9Dimen Research
... Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Commercializing Biomarkers basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost ...  |  read more...
USD 2,850
Global and Chinese Kidney marker Industry, 2016 Market Research Report
4/8/2016 | published by: Prof-Research
... market. The report provides key statistics on the market status of the Kidney marker manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides ...  |  read more...
USD 2,900
Central Nervous System (CNS) Biomarkers: Technologies and Global Markets
3/1/2016 | published by: BCC Research
... of 10.4%. This report provides: An overview of the global market for central nervous system (CNS) biomarkers, which are measurable and quantifiable biological indicators that can be used to diagnose or predict disease, monitor disease ...  |  read more...
USD 6,650
Global Central Nervous System (CNS) Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 – 2022
3/3/2016 | published by: Occams Business Research & Consultancy
... the effects of treatment. For example, prostate specific antigen (PSA) is a biomarker for cancer of prostate. Biomarkers enable the researchers to quickly see large number of biological analytics. In the present scenario, the research ...  |  read more...
USD 3,900
Global Tumor Profiling Technologies Industry 2015 Market Research Report
12/18/2015 | published by: 9Dimen Research
... Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Tumor Profiling Technologies basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; ...  |  read more...
USD 2,850
< prev 1    3  4  5  6  7  8